{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T14:02:19Z","timestamp":1774101739911,"version":"3.50.1"},"reference-count":36,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Rep"],"DOI":"10.3892\/mmr.2022.12640","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T12:12:20Z","timestamp":1644840740000},"source":"Crossref","is-referenced-by-count":8,"title":["Methylation\u2011associated inactivation of JPH3 and its effect on prognosis and cell biological function in HCC"],"prefix":"10.3892","volume":"25","author":[{"given":"Yi","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Pancreatic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"key20220316112145_b1-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12072-018-9919-1","article-title":"Goals and targets for personalized therapy for HCC","volume":"13","author":"Couri","year":"2019","journal-title":"Hepatol Int"},{"key":"key20220316112145_b2-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: Trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20220316112145_b3-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20220316112145_b4-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"16933","DOI":"10.1002\/jcp.28405","article-title":"Junctophilins emerge as novel therapeutic targets","volume":"234","author":"Jiang","year":"2019","journal-title":"J Cell Physiol"},{"key":"key20220316112145_b5-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/WCO.0000000000000386","article-title":"Pathogenic insights from Huntington's disease-like 2 and other Huntington's disease genocopies","volume":"29","author":"Margolis","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"key20220316112145_b6-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.7150\/thno.18185","article-title":"Epigenomic and functional characterization of junctophilin 3 (JPH3) as a novel tumor suppressor being frequently inactivated by promoter CpG methylation in digestive cancers","volume":"7","author":"Hu","year":"2017","journal-title":"Theranostics"},{"key":"key20220316112145_b7-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.3390\/ijms19123978","article-title":"The epigenetic regulation of HCC metastasis","volume":"19","author":"Han","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20220316112145_b8-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: From mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"key20220316112145_b9-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"e1007362","DOI":"10.1371\/journal.pgen.1007362","article-title":"Cancer epigenetics: Movin forward","volume":"14","author":"Nebbioso","year":"2018","journal-title":"PLoS Genet"},{"key":"key20220316112145_b10-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-15-3449-2_1","article-title":"Epigenetics in health and disease","volume":"1253","author":"Zhang","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"key20220316112145_b11-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"BSR20193377","DOI":"10.1042\/BSR20193377","article-title":"Identification of hub genes related to prognosis in glioma","volume":"40","author":"Zhang","year":"2020","journal-title":"Biosci Rep"},{"key":"key20220316112145_b12-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.3892\/ijo.2014.2687","article-title":"Methylation-associated inactivation of LATS1 and its effect on demethylation or overexpression on YAP and cell biological function in human renal cell carcinoma","volume":"45","author":"Chen","year":"2014","journal-title":"Int J Oncol"},{"key":"key20220316112145_b13-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20220316112145_b14-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"key20220316112145_b15-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.3748\/wjg.v25.i25.3151","article-title":"Hepatocellular carcinoma: Mechanisms of progression and immunotherapy","volume":"25","author":"Jiang","year":"2019","journal-title":"World J Gastroenterol"},{"key":"key20220316112145_b16-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41571-018-0002-6","article-title":"The emerging clinical relevance of genomics in cancer medicine","volume":"15","author":"Berger","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"key20220316112145_b17-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1126\/science.355.6332.1386-l","article-title":"Effects of the tumor microenvironment","volume":"355","author":"Zahn","year":"2017","journal-title":"Science"},{"key":"key20220316112145_b18-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"key20220316112145_b19-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"452","DOI":"10.21037\/hbsn-20-480","article-title":"2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: Updates and insights","volume":"9","author":"Xie","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"key20220316112145_b20-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jhep.2018.10.008","article-title":"Hepatocellular carcinoma in the setting of alcohol-related liver disease","volume":"70","author":"Ganne-Carri\u00e9","year":"2019","journal-title":"J Hepatol"},{"key":"key20220316112145_b21-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1042\/EBC20190037","article-title":"The DNA methylation landscape in cancer","volume":"63","author":"Skvortsova","year":"2019","journal-title":"Essays Biochem"},{"key":"key20220316112145_b22-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13072-017-0130-8","article-title":"DNA methylation and DNA methyltransferases","volume":"10","author":"Edwards","year":"2017","journal-title":"Epigenetics Chromatin"},{"key":"key20220316112145_b23-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mam.2016.11.008","article-title":"Epigenetics in non-alcoholic fatty liver disease","volume":"54","author":"Lee","year":"2017","journal-title":"Mol Aspects Med"},{"key":"key20220316112145_b24-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10238-017-0467-0","article-title":"DNA methylation profiles in cancer diagnosis and therapeutics","volume":"18","author":"Pan","year":"2018","journal-title":"Clin Exp Med"},{"key":"key20220316112145_b25-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0140-6736(18)31268-6","article-title":"Principles of DNA methylation and their implications for biology and medicine","volume":"392","author":"Dor","year":"2018","journal-title":"Lancet"},{"key":"key20220316112145_b26-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40169-019-0230-0","article-title":"Epigenetics of hepatocellular carcinoma","volume":"8","author":"Toh","year":"2019","journal-title":"Clin Transl Med"},{"key":"key20220316112145_b27-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.clinre.2013.05.009","article-title":"Methylation and liver cancer","volume":"37","author":"Raggi","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"key20220316112145_b28-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/hepr.13250","article-title":"Epigenetic dysregulation in hepatocellular carcinoma: An up-to-date review","volume":"49","author":"Nakamura","year":"2019","journal-title":"Hepatol Res"},{"key":"key20220316112145_b29-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3892\/ijo.2013.1778","article-title":"Delta-like 3 is silenced by methylation and induces apoptosis in human hepatocellular carcinoma","volume":"42","author":"Maemura","year":"2013","journal-title":"Int J Oncol"},{"key":"key20220316112145_b30-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1471-2407-11-223","article-title":"SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation","volume":"11","author":"Acun","year":"2011","journal-title":"BMC Cancer"},{"key":"key20220316112145_b31-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol"},{"key":"key20220316112145_b32-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/jb\/mvy047","article-title":"Involvement of partial EMT in cancer progression","volume":"164","author":"Saitoh","year":"2018","journal-title":"J Biochem"},{"key":"key20220316112145_b33-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1084\/jem.20181827","article-title":"Context-dependent EMT programs in cancer metastasis","volume":"216","author":"Aiello","year":"2019","journal-title":"J Exp Med"},{"key":"key20220316112145_b34-mmr-25-04-12640","first-page":"3285","article-title":"TDP-43 induces EMT and promotes hepatocellular carcinoma metastasis via activating Wnt\/\u03b2-catenin signaling pathway","volume":"10","author":"Guo","year":"2020","journal-title":"Am J Cancer Res"},{"key":"key20220316112145_b35-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3727\/096504020X15954139263808","article-title":"miR-186 represses proliferation, migration, invasion, and EMT of hepatocellular carcinoma via directly targeting CDK6","volume":"28","author":"Lu","year":"2020","journal-title":"Oncol Res"},{"key":"key20220316112145_b36-mmr-25-04-12640","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.7150\/jca.60008","article-title":"MST4 negatively regulates the EMT, invasion and metastasis of HCC cells by inactivating PI3K\/AKT\/Snail1 axis","volume":"12","author":"Dian","year":"2021","journal-title":"J Cancer"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T09:22:20Z","timestamp":1647422540000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2022.12640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2,14]]}},"URL":"https:\/\/doi.org\/10.3892\/mmr.2022.12640","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"article-number":"124"}}